Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "fda" return 6 results.
PANOQUELL®-CA1 (fuzapladib sodium for injection) is now available in the U.S. >
The first and only drug conditionally approved by the FDA for management of the symptoms associated with acute onset of canine pancreatitis
CEVA LAUNCHES FIRST FDA-APPROVED GENERIC OF MILBEMYCIN OXIME IN U.S. >
Ceva Animal Health has launched MilbeGuard™ (milbemycin oxime) Flavored Tablets, the first FDA-approved generic milbemycin oxime in the U.S. MilbeGuard is a monthly, beef-flavored tablet that preve...
Ceva Animal Health Expands Donation Program to Support Hurricane Pet Relocations >
Ceva urges volunteers to follow new AHS “best practices” to help stop heartworm transmission via transported dogs.
Ceva Animal Health completes integration of Sogeval Animal Health >
Ceva Animal Health’s integration of Sogeval Laboratories is strengthening the company’s ability to provide total pet health solutions to veterinarians and their clients.
Ceva appoints Joe Conti to Vice President, Regulatory Affairs – EPA and FDA >
June 7, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce Joe Conti has been appointed Vice President, Regulatory Affairs for its North American Zone. Joe will report to Craig Wallace, C...
History in the U.S. >
Growing presence in the U.S.